Page last updated: 2024-09-04

gadolinium dtpa and optimark

gadolinium dtpa has been researched along with optimark in 40 studies

Compound Research Comparison

Studies (gadolinium dtpa)	Trials (gadolinium dtpa)	Recent Studies (post-2010) (gadolinium dtpa)	Studies (optimark)	Trials (optimark)	Recent Studies (post-2010) (optimark)
12,654	664	4,051	74	12	26

Research

Studies (40)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (7.50)	18.2507
2000's	23 (57.50)	29.6817
2010's	13 (32.50)	24.3611
2020's	1 (2.50)	2.80

Authors

Authors	Studies
Rozenberg, D; Terk, MR	1
Bluemke, D; Brown, J; Desser, TS; Fultz, P; Ho, V; Kristy, RM; Nelson, R; Nghiem, HV; Pierro, JA; Reimer, P; Rubin, DL; Semelka, R; Stevens, WR	1
Adzamli, K; Koenig, SH; Periasamy, MP; Spiller, M	1
Brunberg, JA; Grodd, W; Grossman, RI; Haughton, VM; Heindel, W; Hunter, G; Jinkins, JR; Kanal, E; Kristy, RM; Kuhn, MJ; Lee, D; Leeds, N; Maravilla, K; Provenzale, JM; Ramsey, R; Rubin, DL; Simon, J; Stevens, GR; Sze, G; Truwit, C; Tu, R; Wippold, FJ; Zelch, J	1
Galen, KP; Wible, JH; Wojdyla, JK	1
Jinkins, JR; Muroff, LR; Runge, VM	1
Brown, JJ; Kristy, RM; Pierro, JA; Stevens, GR	1
Ackerman, JJ; Adzamli, K; Chicoine, MR; Galen, KP; Won, EK; Woolsey, TA; Yablonskiy, DA; Zahner, MC	1
Choyke, PL; Knopp, MV	1
Brock, JM; Buonocore, MH; Ivanovic, M; Katzberg, RW; Ryan, JM	1
Desai, NK; Runge, VM	1
Heiken, J; Joe, BN; Kang, HP; Narra, V; Parvin, CA; Scott, MG	1
Emerson, J; Kost, G	1
Hynes, MR; Wible, JH	1
Balzer, T; Hirt, U; Löwe, A	1
Barboriak, DP; Dale, BM; Merkle, EM	1
Collidge, TA; Mark, PB; Thomson, PC; Traynor, JP	1
Broome, DR; Kanal, E; Martin, DR; Thomsen, HS	1
Reilly, RF	1
Perazella, MA	1
Frenzel, T; Lengsfeld, P; Pietsch, H; Schirmer, H; Sieber, MA; Siegmund, F; Walter, J; Weinmann, HJ	1
Endo, K; Takahashi-Taketomi, A; Tsushima, Y	1
Abramova, L; Arduino, M; Cheng, S; Guarner, J; Hess, T; Jhung, MA; Kallen, AJ; Patel, PR; Pollack, B; Saab, G; Turabelidze, G	1
Connell, JL; Magnotti, RA; Marietta, PM	1
Haylor, J; Morcos, SK; Vickers, ME	1
Frenzel, T; Golfier, S; Hütter, J; Lengsfeld, P; Pering, C; Pietsch, H; Sieber, MA; Steger-Hartmann, T; Walter, J; Weinmann, HJ	1
Burden, AD; Edward, M; Jardine, AG; Newton, BB; Quinn, JA	1
Feng, W; Haacke, EM; Hewett, J; Hubbard, D; Katkuri, Y; Latif, Z; Trifan, G; Utriainen, D; Wu, Z	1
Abu Alfa, AK; Bauer, K; Belknap, SM; Bhatt, K; Bull, C; Cowper, SE; Edwards, BJ; Fisher, MJ; Hammel, JA; Kanal, E; Laumann, AE; McKoy, JM; Miller, FH; Nardone, B; Raisch, DW; Restaino, J; Saddleton, E; Samaras, AT; Thomsen, HS; West, DP	1
Kay, J; Todd, DJ	1
AlObaidy, M; Burke, LM; Jay, M; Ramalho, J; Ramalho, M; Semelka, RC; Vakharia, A	1
Jay, M; Prybylski, JP; Semelka, RC	1
Avenarius, D; Bijnens, B; Iqbal, A; Malm, S; Rösner, A; Schirmer, H	1
Runge, VM	1
Jay, M; Prybylski, JP	1
Arheden, H; Grizzard, JD; Heiberg, E; Kim, HW; Kim, RJ; Klem, I; Parker, MA; Van Assche, L	1
Prybylski, JP; Ramalho, M; Semelka, RC	1
Al Saleh, T; Baalbaki, M; Chehabeddine, L; Hannoun, S; Khoury, SJ; Saleh, E	1
Attari, H; Cao, Y; Elmholdt, TR; Prince, MR; Zhao, Y	1
Davenport, MS; McGrath, TA; McInnes, MDF; Schieda, N; Shankar, T; Walker, DT	1

Reviews

7 review(s) available for gadolinium dtpa and optimark

Article	Year
Central nervous system: review of clinical use of contrast media. Topics in magnetic resonance imaging : TMRI, 2001, Volume: 12, Issue:4 Topics: Central Nervous System Diseases; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds	2001
Contrast use at low field: a review. Topics in magnetic resonance imaging : TMRI, 2003, Volume: 14, Issue:5 Topics: Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Joint Diseases; Magnetic Resonance Imaging; Multiple Sclerosis; Organometallic Compounds	2003
Gadolinium-Induced Fibrosis. Annual review of medicine, 2016, Volume: 67 Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic	2016
Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommend Investigative radiology, 2017, Volume: 52, Issue:6 Topics: Animals; Bone and Bones; Brain; Contrast Media; Europe; Gadolinium; Gadolinium DTPA; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Marketing; Meglumine; Muscle, Skeletal; Organometallic Compounds; Pharmacovigilance; Practice Guidelines as Topic; Risk Assessment	2017
The Impact of Excess Ligand on the Retention of Nonionic, Linear Gadolinium-Based Contrast Agents in Patients With Various Levels of Renal Dysfunction: A Review and Simulation Analysis. Advances in chronic kidney disease, 2017, Volume: 24, Issue:3 Topics: Animals; Computer Simulation; Contrast Media; Gadolinium DTPA; Humans; Ligands; Models, Biological; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Renal Insufficiency, Chronic	2017
A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis. Radiology, 2019, Volume: 292, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Child; Contrast Media; Female; Gadolinium DTPA; Humans; Kidney; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Young Adult	2019
Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis. Radiology, 2020, Volume: 296, Issue:2 Topics: Contrast Media; Drug Hypersensitivity; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Skin Tests	2020

Trials

4 trial(s) available for gadolinium dtpa and optimark

Article	Year
Gadolinium-enhanced MR imaging of traumatic hepatic injury. AJR. American journal of roentgenology, 1998, Volume: 171, Issue:3 Topics: Adult; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Liver; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prospective Studies; Tomography, X-Ray Computed; Wounds, Gunshot; Wounds, Nonpenetrating	1998
A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical Journal of magnetic resonance imaging : JMRI, 1999, Volume: 9, Issue:2 Topics: Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Injections, Intravenous; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Safety	1999
Magnetic resonance imaging in patients with central nervous system pathology: a comparison of OptiMARK (Gd-DTPA-BMEA) and Magnevist (Gd-DTPA). Investigative radiology, 2000, Volume: 35, Issue:7 Topics: Adult; Aged; Brain; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Male; Middle Aged; Organometallic Compounds; Spinal Cord	2000
The OptiMARK clinical development program: summary of safety data. Journal of magnetic resonance imaging : JMRI, 2002, Volume: 15, Issue:4 Topics: Adult; Contrast Media; Drug Tolerance; Female; Gadolinium DTPA; Humans; Kidney Diseases; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Safety	2002

Other Studies

29 other study(ies) available for gadolinium dtpa and optimark

Article	Year
NMRD assessment of Gd-DTPA-bis(methoxyethylamide), (Gd-DTPA-BMEA), a nonionic MRI agent. Investigative radiology, 1999, Volume: 34, Issue:6 Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Ligands; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid	1999
Cardiovascular effects caused by rapid administration of gadoversetamide injection in anesthetized dogs. Investigative radiology, 2001, Volume: 36, Issue:5 Topics: Anesthesia; Animals; Cardiovascular System; Contrast Media; Dogs; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections, Intravenous; Male; Organometallic Compounds; Time Factors	2001
Albumin-binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model. Magnetic resonance in medicine, 2003, Volume: 49, Issue:3 Topics: Albumins; Animals; Brain Neoplasms; Contrast Media; Gadolinium DTPA; Glioma; Image Enhancement; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Models, Animal; Organometallic Compounds	2003
Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale. Radiology, 2003, Volume: 227, Issue:3 Topics: Calcium; Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Hypocalcemia; Injections, Intravenous; Magnetic Resonance Imaging; Organometallic Compounds	2003
Cortical, medullary, and pelvocaliceal MR renography with and without diuretic modification. Academic radiology, 2003, Volume: 10, Issue:7 Topics: Adult; Case-Control Studies; Contrast Media; Diuretics; Feasibility Studies; Female; Furosemide; Gadolinium; Gadolinium DTPA; Humans; Hydronephrosis; Injections, Intravenous; Kidney; Magnetic Resonance Imaging; Male; Organometallic Compounds	2003
Model for predicting the impact of gadolinium on plasma calcium measured by the o-cresolphthalein method. Clinical chemistry, 2004, Volume: 50, Issue:4 Topics: Calcium; Contrast Media; False Positive Reactions; Gadolinium; Gadolinium DTPA; Humans; Indicators and Reagents; Models, Biological; Organometallic Compounds; Phenolphthaleins; Reference Values; Time Factors	2004
Spurious hypocalcemia after Omniscan- or OptiMARK-enhanced magnetic resonance imaging: an algorithm for minimizing a false-positive laboratory value. Archives of pathology & laboratory medicine, 2004, Volume: 128, Issue:10 Topics: Algorithms; Calcium; Diagnostic Errors; False Positive Reactions; Gadolinium DTPA; Humans; Hypocalcemia; Injections, Intravenous; Magnetic Resonance Imaging; Organometallic Compounds	2004
Measurement of serum calcium concentration after administration of gadoversetamide in dogs. Radiology, 2004, Volume: 233, Issue:1 Topics: Analysis of Variance; Animals; Calcium; Chelating Agents; Coloring Agents; Contrast Media; Dogs; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Injections, Intravenous; Male; Mass Spectrometry; Organometallic Compounds; Phenolphthaleins; Time Factors	2004
Interference of gadolinium-containing contrast-enhancing agents with colorimetric calcium laboratory testing. Investigative radiology, 2005, Volume: 40, Issue:8 Topics: Adult; Calcium; Colorimetry; Contrast Media; Diagnostic Errors; False Positive Reactions; Female; Gadolinium DTPA; Humans; Hypocalcemia; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds	2005
Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model. Academic radiology, 2007, Volume: 14, Issue:7 Topics: Abdomen; Adult; Computer Simulation; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Angiography; Magnetics; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Predictive Value of Tests; Signal Processing, Computer-Assisted	2007
Gadolinium contrast may be risky in kidney disease. BMJ (Clinical research ed.), 2007, Jun-30, Volume: 334, Issue:7608 Topics: Contrast Media; Fibromyalgia; Gadolinium; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Angiography; Organometallic Compounds; Peripheral Vascular Diseases; Risk Factors	2007
Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology, 2008, Volume: 246, Issue:1 Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; United States; United States Food and Drug Administration	2008
Risk for nephrogenic systemic fibrosis with gadoteridol (ProHance) in patients who are on long-term hemodialysis. Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:3 Topics: Aged; Contrast Media; Female; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Hospitals, Veterans; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Risk Assessment; Skin Diseases; Texas; Time Factors	2008
How should nephrologists approach gadolinium-based contrast imaging in patients with kidney disease? Clinical journal of the American Society of Nephrology : CJASN, 2008, Volume: 3, Issue:3 Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Kidney Diseases; Kidney Failure, Chronic; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Organometallic Compounds; Patient Selection; Renal Dialysis; Risk Assessment; Skin Diseases; Time Factors	2008
Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand. Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:5 Topics: Animals; Contrast Media; Copper; Fibrosis; Gadolinium; Gadolinium DTPA; Kidney Diseases; Ligands; Male; Organometallic Compounds; Rats; Skin Diseases; Statistics, Nonparametric; Tissue Distribution; Zinc	2008
Nephrogenic systemic fibrosis in Japan: advisability of keeping the administered dose as low as possible. Radiology, 2008, Volume: 247, Issue:3 Topics: Contrast Media; Fibrosis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Renal Insufficiency; Risk; Risk Factors	2008
Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2008, Volume: 51, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Contrast Media; Female; Fibrosis; Gadolinium DTPA; Humans; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Renal Dialysis; Retrospective Studies; Risk Factors; Skin	2008
Automated colorimetric gadolinium assay for verification of clearance and estimation of glomerular filtration rate. Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 399, Issue:1-2 Topics: Animals; Automation; Biological Assay; Cats; Colorimetry; Contrast Media; Gadolinium; Gadolinium DTPA; Glomerular Filtration Rate; Magnetic Resonance Imaging; Mass Spectrometry; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity	2009
Interference of gadolinium-based contrast agents with the measurement of serum creatinine by the Jaffe reaction. The British journal of radiology, 2009, Volume: 82, Issue:977 Topics: Animals; Contrast Media; Creatinine; Gadolinium DTPA; Humans; Kinetics; Meglumine; Organometallic Compounds	2009
Evaluating the role of zinc in the occurrence of fibrosis of the skin: a preclinical study. Journal of magnetic resonance imaging : JMRI, 2009, Volume: 30, Issue:2 Topics: Animals; Contrast Media; Copper; Edetic Acid; Gadolinium DTPA; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Rats, Wistar; Skin; Zinc	2009
Effect of different classes of gadolinium-based contrast agents on control and nephrogenic systemic fibrosis-derived fibroblast proliferation. Radiology, 2010, Volume: 256, Issue:3 Topics: Adult; Cell Proliferation; Collagen; Contrast Media; Dose-Response Relationship, Drug; Edetic Acid; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hyaluronic Acid; Linear Models; Magnetic Resonance Imaging; Meglumine; Middle Aged; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds	2010
Patients with multiple sclerosis with structural venous abnormalities on MR imaging exhibit an abnormal flow distribution of the internal jugular veins. Journal of vascular and interventional radiology : JVIR, 2012, Volume: 23, Issue:1 Topics: Analysis of Variance; Blood Flow Velocity; Constriction, Pathologic; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Jugular Veins; Magnetic Resonance Angiography; Male; Multiple Sclerosis; Organometallic Compounds	2012
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report. The British journal of radiology, 2014, Volume: 87, Issue:1042 Topics: Contrast Media; Cooperative Behavior; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Male; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Pharmacovigilance; Registries; United States	2014
Gadolinium deposition disease: Initial description of a disease that has been around for a while. Magnetic resonance imaging, 2016, Volume: 34, Issue:10 Topics: Adult; Aged; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pain; Prospective Studies	2016
The stability of gadolinium-based contrast agents in human serum: A reanalysis of literature data and association with clinical outcomes. Magnetic resonance imaging, 2017, Volume: 38 Topics: Chelating Agents; Chromatography, High Pressure Liquid; Contrast Media; Data Interpretation, Statistical; Drug Stability; Gadolinium; Gadolinium DTPA; Humans; Kinetics; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Treatment Outcome	2017
Assessment of myocardial ischemia by strain dobutamine stress echocardiography and cardiac magnetic resonance perfusion imaging before and after coronary artery bypass grafting. Echocardiography (Mount Kisco, N.Y.), 2017, Volume: 34, Issue:4 Topics: Cohort Studies; Contrast Media; Coronary Artery Bypass; Dobutamine; Echocardiography, Stress; Female; Gadolinium DTPA; Heart; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Organometallic Compounds; Perfusion Imaging; Postoperative Complications; Preoperative Care; Prospective Studies; Reproducibility of Results	2017
Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2017, Aug-11, Volume: 19, Issue:1 Topics: Aged; Algorithms; Automation, Laboratory; Case-Control Studies; Contrast Media; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Laboratory Proficiency Testing; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Observer Variation; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; ST Elevation Myocardial Infarction; Sweden; United States	2017
Influence of excess ligand on Nephrogenic Systemic Fibrosis associated with nonionic, linear gadolinium-based contrast agents. Magnetic resonance imaging, 2019, Volume: 58 Topics: Adverse Drug Reaction Reporting Systems; Animals; Contrast Media; Databases, Factual; Fibrosis; Gadolinium; Gadolinium DTPA; Humans; Incidence; Kinetics; Ligands; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Rats; Retrospective Studies; Skin Diseases; Thermodynamics; United States	2019
Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents. Critical reviews in toxicology, 2019, Volume: 49, Issue:3 Topics: Adult; Brain; Cerebellar Nuclei; Contrast Media; Environmental Exposure; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds	2019